Literature DB >> 22142653

Clinicopathological consistency in skin disorders: a retrospective study of 3949 pathological reports.

Canan Aslan1, Fatih Göktay, Ayşe Tülin Mansur, Ikbal Esen Aydıngöz, Pembegül Güneş, Tuğba Rezan Ekmekçi.   

Abstract

BACKGROUND: Although the clinicopathological approach plays an important role in skin disorder diagnoses, few studies have evaluated the consistency between clinical and histopathological diagnoses of skin disorders.
OBJECTIVE: We sought to investigate the consistency, and factors affecting consistency, between clinical diagnoses and pathological diagnoses in patients with skin disorders referred for biopsy by dermatologists.
METHODS: We retrospectively examined 3949 pathological reports of biopsy specimens, between 1999 and 2008. The relationships between clinical and pathological diagnoses were studied in 4 groups, namely: (1) definite pathological diagnoses consistent with the clinical diagnoses, (2) descriptive pathological diagnoses consistent with the clinical diagnoses, (3) definite pathological diagnoses inconsistent with the clinical diagnoses, and (4) descriptive pathological diagnoses inconsistent with the clinical diagnoses. The first two groups show consistency, whereas the latter two groups show inconsistency between the diagnoses.
RESULTS: The pathological diagnoses were consistent with the clinical diagnoses in 3034 biopsy reports (76.8%), and they were inconsistent in 915 reports (23.2%). In all types of skin disorders, clinicopathological consistency was higher in patients with sufficient clinical descriptive information. No correlation was observed between clinicopathological consistency and biopsy type, number of clinical diagnoses, or specifying the location of disease. Disease duration was shorter in the biopsy reports showing clinicopathological consistency. Moreover, a statistically significant increase was found in clinicopathological consistency for inflammatory dermatoses, when pathologists evaluated the specimens with clinical diagnoses, in comparison with blind evaluation. LIMITATIONS: The retrospective nature of the study might have resulted in a loss of data.
CONCLUSION: In a dermatology clinic setting, providing sufficient clinical descriptive information for pathology requisition forms increases the probability of making an accurate diagnosis.
Copyright © 2011 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22142653     DOI: 10.1016/j.jaad.2010.12.031

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

Review 1.  Overlapping Features of Psoriasis and Atopic Dermatitis: From Genetics to Immunopathogenesis to Phenotypes.

Authors:  Ya-Chu Tsai; Tsen-Fang Tsai
Journal:  Int J Mol Sci       Date:  2022-05-15       Impact factor: 6.208

2.  Skin biopsy in the context of dermatological diagnosis: a retrospective cohort study.

Authors:  Chrysovalantis Korfitis; Stamatis Gregoriou; Christina Antoniou; Andreas D Katsambas; Dimitris Rigopoulos
Journal:  Dermatol Res Pract       Date:  2014-01-30

3.  Clinicopathological concordance in the diagnosis of skin diseases: a retrospective analysis of 5000 histopathology reports.

Authors:  Fahad Mohammed Al-Saif; Salman Abdulaziz Binsufayan; Abdulaziz Hasan Alhussain; Tuqa Morad Alkaff; Hesham Mohammed Alshaikh; Mosfer Saeed Aldosari; Saud Abdulaziz Binsufayan; Rawan Murshed AlTaleb; Hend Metia Alotaibi; Mohammed Abdulaziz Alshahwan
Journal:  Ann Saudi Med       Date:  2019-12-05       Impact factor: 1.526

4.  Clinicopathological Concordance in 2216 Cases of Skin Biopsy over One Year: An Indian Experience.

Authors:  Akanksha Malik; Fouzia Siraj; Sharma Shruti; Pooja Gupta; Geeti Khullar; V Ramesh
Journal:  Cureus       Date:  2020-04-20

5.  Routine Clinical-Pathologic Correlation of Pigmented Skin Tumors Can Influence Patient Management.

Authors:  Caterina Longo; Simonetta Piana; Aimilios Lallas; Elvira Moscarella; Mara Lombardi; Margherita Raucci; Giovanni Pellacani; Giuseppe Argenziano
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.